Psoriasis exacerbation after COVID ‐19 vaccination in high‐risk group: How to manage it?
Open Access
- 17 February 2022
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 35 (5) , e15368
Abstract
Click on the article title to read more.Keywords
This publication has 9 references indexed in Scilit:
- Cutaneous findings following COVID‐19 vaccination: review of world literature and own experienceJournal of the European Academy of Dermatology and Venereology, 2021
- Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccinesCell Discovery, 2021
- New‐onset and exacerbations of psoriasis after mRNA COVID‐19 vaccines: two sides of the same coin?Journal of the European Academy of Dermatology and Venereology, 2021
- Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.Frontiers in Public Health, 2021
- Psoriasis flare‐up associated with second dose of Pfizer‐BioNTech BNT16B2b2 COVID‐19 mRNA vaccineJournal of the European Academy of Dermatology and Venereology, 2021
- SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesScience Immunology, 2021
- BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humansNature, 2021
- Psoriasis flare after influenza vaccination in Covid‐19 era: A report of four cases from a single centerDermatologic Therapy, 2020
- Dendritic cells: The driver of psoriasisThe Journal of Dermatology, 2019